Explore the words cloud of the GLIOHAB project. It provides you a very rough idea of what is the project "GLIOHAB" about.
The following table provides information about the project.
Coordinator |
OSLO UNIVERSITETSSYKEHUS HF
Organization address contact info |
Coordinator Country | Norway [NO] |
Total cost | 214˙158 € |
EC max contribution | 214˙158 € (100%) |
Programme |
1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility) |
Code Call | H2020-MSCA-IF-2018 |
Funding Scheme | MSCA-IF-EF-ST |
Starting year | 2019 |
Duration (year-month-day) | from 2019-06-01 to 2021-05-31 |
Take a look of project's partnership.
# | ||||
---|---|---|---|---|
1 | OSLO UNIVERSITETSSYKEHUS HF | NO (OSLO) | coordinator | 214˙158.00 |
Glioblastoma is not only the most frequent but also the most malignant tumour originating in the Central Nervous System. Due to the extremely complex and heterogeneous molecular biology of this tumour “the same treatment for all” approach does not work well in this disease, and standard of care is not always the best option. The intra-patient tumor heterogeneity is one of the responsible factors for the high aggressiveness of these lethal solid tumors and their resistance against effective therapies. In this context, additional efforts are needed for generate novel strategies able to define more tailored personalized treatments that facilitate higher safety and efficacy for relevant sub-populations. GLIOHAB project will develop an artificial intelligence based medical device able to monitor the functional state of the glioblastoma at pixel level. This software will be built on technologies previously co-developed, validated, and patented by the researcher. GLIOHAB will join best experts in the field, in a multidisciplinary and eminently clinical environment, which will provide the optimum conditions for a holistic approach to the solution. This proposal includes both the transfer of knowledge to the host institution and the training of the candidate in new advanced techniques. GLIOHAB results will contribute to monitor the response of highly aggressive tumours to complex treatments, and generate stratification strategies to select treatment responder patients.
year | authors and title | journal | last update |
---|---|---|---|
2019 |
MarÃa del Mar Ãlvarezâ€Torres, Javier Juanâ€AlbarracÃn, Elies Fusterâ€Garcia, Fuensanta BellvÃsâ€Bataller, David Lorente, Gaspar Reynés, Jaime Font de Mora, Fernando Apariciâ€Robles, Carlos Botella, Jose Muñozâ€Langa, Raquel Faubel, Sabina Asensioâ€Cuesta, Germán A. GarcÃaâ€Ferrando, Eduard Chelebian, Cristina Auger, Jose Pineda, Alex Rovira, Laura Oleaga, Enrique Mollà â€Olmos, A Robust association between vascular habitats and patient prognosis in glioblastoma: An international multicenter study published pages: , ISSN: 1053-1807, DOI: 10.1002/jmri.26958 |
Journal of Magnetic Resonance Imaging | 2019-11-22 |
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "GLIOHAB" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "GLIOHAB" are provided by the European Opendata Portal: CORDIS opendata.